Skip to main content

Otsuka Holdings

Otsuka Holdings Co., Ltd. is a major global healthcare and nutraceutical group headquartered in Tokyo, Japan, operating a diverse network of specialized subsidiaries. The company operates primarily across two complementary business segments: prescription pharmaceuticals focused on central nervous system disorders and oncology, and functional nutraceutical consumer products. Its diverse product portfolio encompasses prescription medicines, medical diagnostic devices, functional rehydration beverages, clinical nutrition, and consumer skincare formulations. Widely recognized for creating innovative psychiatric medications and popular wellness beverages like Pocari Sweat, Otsuka effectively bridges medical science with everyday consumer health. To address the growing health demands of an aging global population, the firm actively develops targeted therapies for Alzheimer's disease, cognitive decline, and chronic age-related metabolic disorders. The corporation invests heavily in clinical research programs, biotechnology partnerships, and research facilities across Asia, North America, and Europe. Dedicated to holistic wellbeing, Otsuka Holdings remains committed to delivering creative healthcare solutions that promote long-term human vitality.

69 of the funds FundTelligence covers report a position in Otsuka Holdings.

Legal name
Otsuka Holdings Co LTD
Sector
Health Care
Country
Japan
Funds holding it
69
Exposure themes
Mental Health, Psychiatry, Schizophrenia & Psychosis

Funds holding Otsuka Holdings

Showing the 8 largest of 69 funds holding it.

Loading...